TRT vs HRT: What's the Difference?

Written by Empire Medical Training Editorial Team

Medically reviewed by Betsy Greenleaf, DO Board-Certified OB/GYN & Urogynecologist; Empire Director of Anti-Aging

Updated June 2026 ·11 min read

Few terms in hormone medicine get tangled together as often as TRT and HRT. Patients arrive having read both, sometimes using them as synonyms, sometimes treating them as opposites. They are neither. The honest answer is that one is a narrow, specific therapy and the other is a broad umbrella — and the most common point of confusion is that, technically, the first sits inside the second. This guide untangles the terminology, then shows how a trained provider moves past the label to the question that actually matters: which hormones are deficient in this patient?

This is clinical education for providers, written within Empire's broader work on hormone replacement therapy. It is not medical advice, a treatment recommendation, or a substitute for individualized care and current standards.

The quick answer (and why the terms are confusing)

Start with what each abbreviation literally means. HRT stands for hormone replacement therapy — replacing a hormone the body no longer makes in adequate amounts. That is a deliberately wide definition. It includes estrogen and progesterone for a menopausal woman, testosterone for a hypogonadal man, thyroid hormone, DHEA, and more. TRT stands for testosterone replacement therapy, which is replacement of one specific hormone. By that logic, TRT is simply HRT applied to testosterone.

So why does the field talk as if they were two different things? Largely convention and marketing. Over time, “TRT” became the term used for men restoring testosterone, while “HRT” got associated with women managing menopause with estrogen and progesterone. That shorthand is useful, but it breaks down quickly — women lose testosterone too, men have estrogen and progesterone that matter, and a thoughtful regimen rarely touches only one hormone. As Dr. Betsy Greenleaf frames it in Empire's course, everyone carries estrogen, progesterone, and testosterone; the difference between male and female physiology is proportion, not presence. Once you accept that, the TRT-versus-HRT distinction stops being a category and becomes a description of which hormone you happen to be discussing.

What TRT is

Testosterone replacement therapy restores testosterone in patients whose levels have fallen below the range appropriate for their physiology. The need is real and common: there is a natural decline in testosterone with age, and roughly 38% of men over 45 experience hypogonadism, compared with about 7% of men under 40. Low testosterone in men can present as reduced sex drive, erectile difficulty, low sperm count, fatigue, decreased muscle mass, increased body fat, lower bone density, and mood changes.

Testosterone is a controlled substance, and for good reason — patients feel notably better on it, which creates a temptation to overshoot, especially as hormone insensitivity develops over time. Pushed too high, testosterone can drive elevated hematocrit, cardiovascular risk, acne and oily skin, hair loss, mood changes and aggression, fluid retention, testicular atrophy, and suppression of the body's own production. That is why the governing principle is start low, go slow, and why monitoring is non-negotiable. For a deeper treatment of the male side, see our overview of testosterone replacement therapy.

What HRT (and BHRT) is

HRT is the larger category, and in practice it most often refers to managing the hormonal decline of perimenopause and menopause in women. Perimenopause can begin in the mid-thirties and brings the hallmark signs of imbalance — irregular periods, heavy or light bleeding, moodiness, night sweats, hot flashes, weight changes, and shifts in libido. The primary female sex hormones are estrogen and progesterone, and replacing them appropriately is the heart of female HRT. Female-focused regimens are covered in detail in our guide to BHRT for women, and the estrogen component specifically in estrogen replacement therapy.

The “B” in BHRT — bioidentical hormone replacement therapy — matters here, because it cuts across both TRT and HRT. Bioidentical hormones are molecularly identical to the estradiol, progesterone, and testosterone the body makes. Synthetic and horse-derived analogs exist largely for business reasons: naturally occurring molecules cannot be patented, so they are tweaked into novel, patentable compounds. Those altered molecules carry an increased risk profile — oral birth-control hormones, for instance, are not bioequivalent to the body's own. A bioidentical approach can apply equally to a man's testosterone and a woman's estrogen, which is one more reason TRT and HRT are best seen as branches of the same tree.

TRT vs HRT/BHRT: side-by-side

The table below contrasts the two as the terms are commonly used — TRT meaning testosterone replacement (typically male) and HRT/BHRT meaning broader hormone replacement (typically the menopausal female regimen). Remember that these are conventions, not rigid biological boundaries.

One row deserves emphasis: delivery. Both TRT and HRT can be administered by pellet, and pellet therapy is where the two regimens visually converge in a clinical practice — the same insertion technique places testosterone for a man and a tailored bioidentical blend for a woman. The trade-offs between pellets and other routes are their own topic.

Where TRT and HRT overlap

The clean lines of the table blur in real patients, and good care lives in that overlap. Three points make it concrete:

• Men have estrogen and progesterone too. Testosterone can aromatize into estradiol, so a man on TRT can end up with high estradiol and low testosterone if conversion runs unchecked — a pattern Dr. Greenleaf demonstrates in the course's lab cases. Managing that may involve addressing the conversion, which is squarely an HRT-style consideration applied to a “TRT” patient.
• Women get testosterone. Testosterone declines in women as the ovaries fail; most postmenopausal testosterone is made in the adrenal glands. Low testosterone in women shows up as fatigue, reduced libido, low mood, and lost muscle and bone. So a female “HRT” plan frequently includes testosterone — TRT inside HRT.
• BHRT spans both. A bioidentical philosophy applies identically to a man's testosterone and a woman's full panel. And because hormones convert into one another, even a testosterone-only patient may need uterine protection-style thinking when the supplemented hormone can downstream into estrogen.

How trained providers choose

Here is the reframe that resolves the whole TRT-versus-HRT debate: providers don't choose a label, they choose hormones to replace based on the patient's symptoms and labs. The decision is individualized, not categorical. A full panel often reveals a more complex picture than the patient's chief complaint suggests — the man who came in for “low T” whose DHEA is low, estradiol is high, and TSH is elevated needs a plan that touches several hormones, not a single prescription.

Because bioidentical products are largely unpatentable, there is little funding for large trials, so robust standardized dosing data are limited. Dr. Greenleaf's stated best practice is therefore to keep patients within normal laboratory ranges for their identity, start low and go slow, and treat labs as supportive evidence alongside symptoms rather than as the sole target. Two safety habits anchor the work regardless of whether you call it TRT or HRT:

• Uterine protection in women is essential whenever estrogen is supplemented — and, because hormones convert into one another, it must also be considered with testosterone and DHEA. Options include oral micronized progesterone, topical progesterone, or a progesterone-containing IUD. The specific dosing thresholds and equivalencies are taught in Empire's course.
• Watch aromatization in men. When labs don't make sense or a man isn't responding, conversion to estrogen — sometimes driven by endocrine disruptors — should be on the differential. Management strategies are covered in the curriculum rather than reproduced here, because dosing and selection belong to trained, supervised practice.

The takeaway for any clinician: stop asking “TRT or HRT?” and start asking “which hormones, in what form, monitored how?” That is the question Empire's hormone training is built to answer.

Training to offer TRT and HRT

Offering hormone therapy competently — for men, women, or both — requires more than a prescription pad. It requires fluency in hormone physiology and the conversion pathways, lab interpretation, the bioidentical-versus-synthetic distinction (see our guide to bioidentical vs synthetic hormones), delivery methods, dosing principles, uterine protection, contraindications, and structured monitoring. Pellet delivery in particular is a hands-on skill with its own insertion technique.

Empire Medical Training's hormone curriculum — taught by Dr. Betsy Greenleaf — covers both the testosterone (TRT) and broader bioidentical (HRT/BHRT) sides in one program, including the hormone pellet training that lets providers deliver either regimen by pellet. The science here is the why; the full protocols, dosing, and procedure are taught in the course.